KRAS and breast carcinoma: To follow subcellular localization of H-ras and K-ras during TGFβ treatment we used breast cancer cell line MCF7 and transfected it with GFP tagged constitutively active GTP-bound H-ras G12V and K-ras G12V (Fig. 1a).